BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26459252)

  • 1. Compliance to radiation therapy of head and neck cancer patients and impact on treatment outcome.
    Ferreira BC; Sá-Couto P; Lopes MC; Khouri L
    Clin Transl Oncol; 2016 Jul; 18(7):677-84. PubMed ID: 26459252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypopharyngeal squamous cell carcinoma: Three-dimensional or Intensity-modulated radiotherapy? A single institution's experience.
    Katsoulakis E; Riaz N; Hu M; Morris L; Sherman E; McBride S; Lee N
    Laryngoscope; 2016 Mar; 126(3):620-6. PubMed ID: 26597398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicity and outcomes in combined modality treatment of head and neck squamous cell carcinoma: cisplatin versus cetuximab.
    Ye AY; Hay JH; Laskin JJ; Wu JS; Ho CC
    J Cancer Res Ther; 2013; 9(4):607-12. PubMed ID: 24518704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of recurrence after selective postoperative radiation therapy for patients with head and neck squamous cell carcinoma.
    Murakami N; Matsumoto F; Yoshimoto S; Ito Y; Mori T; Ueno T; Tuchida K; Kashihara T; Kobayashi K; Harada K; Kitaguchi M; Sekii S; Umezawa R; Takahashi K; Inaba K; Igaki H; Itami J
    BMC Cancer; 2016 Mar; 16():192. PubMed ID: 26951089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of average weekly dose of radiation during radiotherapy alone or chemoradiotherapy in head and neck cancer.
    Dragovic AF; Bonner JA; Spencer SA; Nabell LM; Carroll WR; Caudell JJ
    Head Neck; 2011 Nov; 33(11):1551-6. PubMed ID: 21990218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined modality treatment outcomes for head and neck cancer: comparison of postoperative radiation therapy at academic vs nonacademic medical centers.
    George JR; Yom SS; Wang SJ
    JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1118-26. PubMed ID: 24051518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.
    Eisbruch A; Marsh LH; Dawson LA; Bradford CR; Teknos TN; Chepeha DB; Worden FP; Urba S; Lin A; Schipper MJ; Wolf GT
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):28-42. PubMed ID: 15093896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation-induced hypothyroidism after treatment of head and neck cancer.
    Feen Rønjom M
    Dan Med J; 2016 Mar; 63(3):. PubMed ID: 26931197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Submandibular gland-sparing intensity modulated radiotherapy in the treatment of head and neck cancer: sites of locoregional relapse and survival.
    Collan J; Kapanen M; Mäkitie A; Nyman H; Joensuu H; Tenhunen M; Saarilahti K
    Acta Oncol; 2012 Jul; 51(6):735-42. PubMed ID: 22150115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nomogram to predict loco-regional control after re-irradiation for head and neck cancer.
    Riaz N; Hong JC; Sherman EJ; Morris L; Fury M; Ganly I; Wang TJ; Shi W; Wolden SL; Jackson A; Wong RJ; Zhang Z; Rao SD; Lee NY
    Radiother Oncol; 2014 Jun; 111(3):382-7. PubMed ID: 24993329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intensity-modulated radiation therapy for head and neck cancers with bilateral irradiation of the neck : preliminary results].
    Lapeyre M; Marchesi V; Mege A; Aletti P; Graff P; Racadot S; Noel A; Marchal C
    Cancer Radiother; 2004 Jun; 8(3):134-47. PubMed ID: 15217581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study.
    Bentzen J; Toustrup K; Eriksen JG; Primdahl H; Andersen LJ; Overgaard J
    Acta Oncol; 2015 Jul; 54(7):1001-7. PubMed ID: 25629651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volumetric stratification of cT4 stage head and neck cancer.
    Studer G; Glanzmann C
    Strahlenther Onkol; 2013 Oct; 189(10):867-73. PubMed ID: 24002381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uniform FDG-PET guided GRAdient Dose prEscription to reduce late Radiation Toxicity (UPGRADE-RT): study protocol for a randomized clinical trial with dose reduction to the elective neck in head and neck squamous cell carcinoma.
    van den Bosch S; Dijkema T; Kunze-Busch MC; Terhaard CH; Raaijmakers CP; Doornaert PA; Hoebers FJ; Vergeer MR; Kreike B; Wijers OB; Oyen WJ; Kaanders JH
    BMC Cancer; 2017 Mar; 17(1):208. PubMed ID: 28327089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reirradiation of Recurrent and Second Primary Head and Neck Cancer With Proton Therapy.
    McDonald MW; Zolali-Meybodi O; Lehnert SJ; Estabrook NC; Liu Y; Cohen-Gadol AA; Moore MG
    Int J Radiat Oncol Biol Phys; 2016 Nov; 96(4):808-819. PubMed ID: 27788954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of intensity-modulated radiotherapy versus conventional radiotherapy for hypopharyngeal cancer.
    Mok G; Gauthier I; Jiang H; Huang SH; Chan K; Witterick IJ; O'Sullivan B; Waldron JN; Bayley AJ; Cho BC; Cummings BJ; Dawson LA; Hope AJ; Kim JJ; Ringash J
    Head Neck; 2015 May; 37(5):655-61. PubMed ID: 24590756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of cumulative dose of cisplatin on outcome of patients with head and neck squamous cell carcinoma.
    Al-Mamgani A; de Ridder M; Navran A; Klop WM; de Boer JP; Tesselaar ME
    Eur Arch Otorhinolaryngol; 2017 Oct; 274(10):3757-3765. PubMed ID: 28755023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromuscular electrical stimulation improves radiation-induced fibrosis through Tgf-Β1/MyoD homeostasis in head and neck cancer.
    Peng G; Masood K; Gantz O; Sinha U
    J Surg Oncol; 2016 Jul; 114(1):27-31. PubMed ID: 27144672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IAEA-HypoX. A randomized multicenter study of the hypoxic radiosensitizer nimorazole concomitant with accelerated radiotherapy in head and neck squamous cell carcinoma.
    Hassan Metwally MA; Ali R; Kuddu M; Shouman T; Strojan P; Iqbal K; Prasad R; Grau C; Overgaard J
    Radiother Oncol; 2015 Jul; 116(1):15-20. PubMed ID: 25913070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensity-modulated versus 3-dimensional conformal radiotherapy in the definitive treatment of esophageal cancer: comparison of outcomes and acute toxicity.
    Haefner MF; Lang K; Verma V; Koerber SA; Uhlmann L; Debus J; Sterzing F
    Radiat Oncol; 2017 Aug; 12(1):131. PubMed ID: 28810885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.